Turn this role into an interview — a resume and cover letter built around what this employer wants.
Lilly in Indianapolis, IN seeks Associate Director, R&D Cardiometabolic Health Communications to lead data communications strategy across preclinical to first regulatory approval, coordinating with CMH portfolio leaders and enterprise science storytelling.
You will guide data readouts, plan congress presence, publications strategy with medical affairs, and advise senior R&D and TA leaders on communications. This role anchors Lilly's public narrative in a fast-evolving field.
At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.
At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We are looking for people who are determined to make life better for people around the world.
The Associate Director, R&D Cardiometabolic Health Communications is the dedicated communications lead for Lilly's cardiometabolic health pipeline, accountable for core deliverables: data congress strategy and milestone data communications. This role is embedded with LRL counterparts in cardiometabolic health and maintains a dotted-line relationship with the Cardiometabolic Health TA communications lead. Lilly's cardiometabolic portfolio is one of the most expansive in the industry, spanning incretins, cardiovascular disease, metabolic dysfunction-associated steatohepatitis (MASH), and related conditions. This therapeutic area sits at the center of Lilly's growth story and public narrative. Reporting to the Senior Director, Global Data Storytelling Communications, the Associate Director leads communications across the scientific lifecycle for cardiometabolic health assets, from pre-clinical through first regulatory approval, ensuring every data moment is strategically planned, narratively connected to the enterprise science story, and executed with the quality and ambition that reflects Lilly's position as the world's most valuable healthcare company. This is a trusted advisor to senior R&D and TA leaders.
Partner with medical affairs and R&D to align publications strategy with communications objectives. Ensure peer-reviewed data disclosures reinforce the corporate narrative and are supported by proactive media and stakeholder engagement.